Who is sponsoring NCT04723524?

NCT04723524 is sponsored by University of Karachi.

Is NCT04723524 still recruiting?

NCT04723524 is currently completed. Last updated 22 June 2022.

Last reviewed 2022-06-22 · How we verify

NCT04723524: RCT

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Jinhua Qinggan Granules in the Treatment of COVID-19

Completed Phase 2 Last updated 22 June 2022

What this trial tests

Phase 2 trial testing Jinhua Qinggan (JHQG) Granules, Traditional Chinese Medicine in COVID-19 in 402 participants. Completed in 23 August 2021.

Timeline

22 September 2020

Primary endpoint
23 August 2021

23 August 2021

Quick facts

Lead sponsor	University of Karachi
Phase	Phase 2
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	402
Start date	22 September 2020
Primary completion	23 August 2021
Estimated completion	23 August 2021
Sites	1 location across Pakistan

Drugs / interventions tested

Jinhua Qinggan (JHQG) Granules, Traditional Chinese Medicine
Placebo Comparator

Conditions studied

COVID-19 — all drugs for COVID-19 →

Sponsor

University of Karachi

Who can join

Adults 18 to 75, any sex, with COVID-19. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The clinical trial is designed to be randomized, double blind, placebo controlled, to evaluate the effectiveness and safety of Jinhua Qinggan granules (JHQG) on mild-category patients of COVID-19 in Pakistani population with the age limit of 18-75 years, at10th day comprehensive follow-up. The informed consent form must be signed by the subjects before their participation in the trial.

Publications & conference data

4 peer-reviewed publications reference this trial (live from Europe PMC):

Jinhua Qinggan granules for non-hospitalized COVID-19 patients: A double-blind, placebo-controlled, and randomized controlled trial.
Shah MR, Fatima S, Khan SN, Ullah S, et al · · 2022 · cited 19× · PMID 35979216 · DOI 10.3389/fmed.2022.928468
COVID-19 Therapeutic Potential of Natural Products.
Low Z, Lani R, Tiong V, Poh C, et al · · 2023 · cited 15× · PMID 37298539 · DOI 10.3390/ijms24119589
Efficacy and potential mechanisms of Chinese herbal compounds in coronavirus disease 2019: advances of laboratory and clinical studies.
Xiang MF, Jin CT, Sun LH, Zhang ZH, et al · · 2021 · cited 10× · PMID 34861881 · DOI 10.1186/s13020-021-00542-y
Jinhua Qinggan Granules for Nonhospitalized COVID-19 Patients: a Double-Blind, Placebo-Controlled, Randomized Controlled Trial
Shah MR, Fatima S, Khan SN, Shafiullah, et al · · 2022 · DOI 10.1101/2022.05.16.22275074

Verify or expand the search:

Other recruiting trials for COVID-19

Currently open trials in the same condition.

NCT07183709 — Safety and Immunogenicity Trial of PepGNP-COVID19 Vaccine in Adults · Phase 1 · active not recruiting
NCT07300839 — A Study to Learn About a COVID-19 Vaccine in Healthy Adults 50 Through 64 Years of Age · Phase 3 · active not recruiting
NCT07221162 — A Safety and Immunogenicity Trial of Boost-2867 Vaccine, Via Intranasal and Intramuscular Routes · Phase 1 · recruiting
NCT07215520 — Safety and Tolerability of a Newcastle Disease Virus-Based Mucosal COVID-19 Vaccine in Previously Vaccinated Adults · Phase 2 · recruiting
NCT07222384 — A Study to Learn About BNT162b2 (LP.8.1)-Adapted Vaccine Against SARS-CoV-2 in Children 5 Through 11 Years of Age That A · Phase 3 · active not recruiting

Other University of Karachi trials

Trials by the same sponsor.

NCT07496099 — Effects of Post-Isometric Relaxation and Myofascial Release on Low Back Pain With Lower Cross Syndrome · NA · not yet recruiting
NCT07396233 — Effects of Diagonal Proprioceptive Neuromuscular Facilitation Patterns on Pain and Functional Outcomes in Patients With · NA · recruiting
NCT07332845 — Symmetrical Scapula-pelvis Proprioceptive Neuromuscular Facilitation and Superficial Back Line in Chronic Neck Pain With · NA · recruiting
NCT07205042 — Walking for Hypothyroidism Trial (WHT) · NA · not yet recruiting
NCT06960330 — Wearable Biofeedback Devices for Remote Physiotherapy and Rehabilitation · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04723524 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of Karachi
Last refreshed: 22 June 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04723524.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing